We next investigated whether these tumours had an infiltration of T cells (CD103, CD4, CD3, and CD8) and B cells (CD20) or expressed immune checkpoints (PD-L1, TIGIT, and LAG3) (Table 3) as these features are known to positively correlate with a response to immunotherapy [40,41]. This evidence concerns the gene CD4 and neoplasm.